Piper Jaffray Downgrades Synageva BioPharma (GEVA) to Neutral
Tweet
Share
E-mailGet Alerts GEVA Hot Sheet
Price: $238.60 --0%
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 38 | New: 4
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 38 | New: 4
Join SI Premium – FREE
Piper Jaffray downgraded Synageva BioPharma (NASDAQ: GEVA) from Overweight to Neutral with a price target of $57.00 (from $66.00).
For an analyst ratings summary and ratings history on Synageva BioPharma click here. For more ratings news on Synageva BioPharma click here.
Shares of Synageva BioPharma closed at $47.87 yesterday.
For an analyst ratings summary and ratings history on Synageva BioPharma click here. For more ratings news on Synageva BioPharma click here.
Shares of Synageva BioPharma closed at $47.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Manulife Financial (MFC:CN) (MFC) PT Raised to Cdn$67 at RBC Capital
- Frontdoor Inc. (FTDR) PT Raised to $100 at Oppenheimer
- Argus Upgrades SpaceX (SPCX) to Buy
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
